FindTrial
Sign In

Clinical investigation for the early screen, diagnosis and standardized transfer of pernicious placenta previa

Clinical investigation for the early screen, diagnosis and standardized transfer of pernicious placenta previa

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018671
Enrollment
Unknown
Registered
2018-10-02
Start date
2018-10-15
Completion date
Unknown
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placenta previa

Interventions

Placenta previa group:Consultant from Ultrasound or MRI
Control group:No

Sponsors

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Pregnant women aged 18 to 45 years old; 2. Cases with scarred uterus and suspected placenta previa during pregnancy period; 3. Patients who sign the informed consent and agree to participate in this experiment.

Exclusion criteria

Exclusion criteria: 1. Patients who will not deliver in Shanghai; 2. Patients with severe liver or kidney dysfunctions or other indicators of continued pregnancy; 3. Patients with malignant tumors or other acute or chronic infections.

Design outcomes

Primary

MeasureTime frame
Placenta accreta;Postpartum heamorragh;Hysterectomy;—

Secondary

MeasureTime frame
Neonatal outcomes;Puerperal infection;Blood Transfusion;MDT;PPH Prophylactic methods;—

Countries

China

Contacts

Public ContactLin Zhang

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

zhanglin01@xinhuamed.com.cn+86 15821124166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026